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Abstract
The diagnostic of orphan genetic disease is often a puzzling task as less attention is paid to the elucidation of the
pathophysiology of these rare disorders at the molecular level. We present here a multidisciplinary approach using
molecular modeling tools and surface plasmonic resonance to study the function of the ATP7B protein, which is impaired in
the Wilson disease. Experimentally validated in silico models allow the elucidation in the Nucleotide binding domain (N-
domain) of the Mg
2+-ATP coordination site and answer to the controversial role of the Mg
2+ ion in the nucleotide binding
process. The analysis of protein motions revealed a substantial effect on a long flexible loop branched to the N-domain
protein core. We demonstrated the capacity of the loop to disrupt the interaction between Mg
2+-ATP complex and the N-
domain and propose a role for this loop in the allosteric regulation of the nucleotide binding process.
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Introduction
The Wilson disease (WD, OMIM 277900) is due to mutations
in a copper transporter gene coding for the protein ATP7B that
belongs to the P-type ATPase superfamily [1]. It is a rare and
serious inherited sickness with the main clinical manifestations
resulting in a systemic copper accumulation (liver, brain…). The
incidence of this autosomic recessive disease is estimated at one for
30,000 to one for 100,000 individuals depending on the ethnicity
of the affected population [2]. With a wide clinical spectrum and a
slow progressive evolution, since liver will tolerate copper
accumulation, early clinical diagnosis of WD remains difficult.
This explains why patient condition is so serious when symptoms
appear, like liver disease such as cirrhosis, neurologic disturbances
or even psychiatric signs [3]. The standard diagnostic is based on
the exploration of copper metabolism (copper, caeruloplasmin…)
and molecular analysis of ATP7B gene mutations. The genetic
diagnosis is difficult and may sometimes be a bottomless problem
since WD has a marked genetic heterogeneity and most of the
affected individuals are compound heterozygotes. Indeed, with a
gene coding region of 4.3 kb and 21 exons, a full PCR
amplification is out of reach in daily laboratory routine. Besides,
more than 300 different mutations and 100 genetic polymor-
phisms have been published so far [4]. Even though some
mutations are more frequent depending on the tested population,
e.g. H1069Q in Caucasians [5] and R778L in Asians [6]. The
pathogenesis of the disease is better understood since the discovery
of the culprit gene (Atp7b) in 1993 [7]. The function of the protein
in copper metabolism has been studied by using biochemical
assays [8], cellular (hepatocytes) and in vivo models to decipher its
cellular trafficking that mediates the export of the ion in different
organs [9]. Human ATP7B is a copper ATPase (P35670) that
shares the general domain organization of P-ATPases (Figure 1A).
This transmembrane protein contains four domains with both N-
and C-terminal ends located in the cytosol. An original metal
binding site is composed of six distinct Copper Binding Domains
(CBD) located in the N-terminal cytosolic part of the protein. The
other domains are the Actuator domain, the Phosphorylation
domain (P-domain) and the Nucleotide-binding domain (N-
domain). This latter domain holds the ATP binding site and plays
a major role in the catalytic cycle (Figure 1B). Experiments have
been dedicated to the study of the impact of ATP7B mutations.
Alterations of the molecular integrity of the ATP7B are
responsible of a partial or total loss of function. For instance,
yeast complementation assays have been successfully used to study
ATP7B function. Despite being time consuming and highly skilled
techniques, they allowed a deeper understanding of the pathogenic
impact of mutations identified in different regions such as ATP-
binding region composed of the N- and P-domain [10].
In parallel, structural studies concerning different domains of
the ATP7B protein have been published. The N-domain structure
studied in the present work was first obtained by NMR [11],
followed by CBD5 and CBD6 [12]. Further studies led to the
elucidation of CBD3 and CBD4 structures [13]. More recently,
the Actuator domain (A-domain) of ATP7B was solved by
heteronuclear NMR spectroscopy [14]. ATP is crucial for ATP7B
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ATP7B that promote copper transport. The topology of the ATP
binding site remains to be precisely defined despite NMR data
available of the N-domain without and with ATP showing the
existence of chemical shifts signals between ATP and protein
residues belonging for instance to a poly-glycine loop [11].
However, Mg
2+ ion is always absent from all structural and
molecular modeling studies [11,15,16] despite the experimental
demonstration of its great participation to the N-domain ATP
affinity [17]. Most of all, attempts were made to clarify ATP/N-
domain interactions without considering the role of the ion.
Therefore, no clear nucleotide-binding site could have been
proposed. The N-domain of the human ATP7B protein bears an
intriguing long loop (A1114 - T1143) connected to the poly-glycine
loop, which is absent in the ATP binding domain of other proteins
of the P-ATPase family (SERCA, ZntA, CopA…) [18]. All the
above observations, together with currently available unconvincing
genotype-phenotype correlation data [19], call for the emergence of
alternative methods such as molecular modeling, to investigate WD
mutants with a clear protocol and highly accurate tools.
In the present study, the wild type (WT) N-domain structure was
investigated by molecular dynamics (MD) simulations. The 3D
structureofthe apoform oftheATP7BN-domain[11] wasused asa
starting point to characterize the amino acids involved in the
nucleotide binding of the wild type protein (WT). By means of 3D
structural alignments and MD simulations validated by binding
affinity measurements, an original ATP binding site is proposed
where Mg
2+ ion is hexacoordinated by the nucleotide and
carboxylate residues of protein. The in silico 3D model proposed
here also provides answers to the controversial issue on the
magnesium role in the process of ATP binding as well as its impact
on the dynamic of the N-domain. We propose a mechanism for the
transitionof the nucleotide between two bindingmodes (+/2 Mg
2+)
with the allosteric participation of a long protruding loop.
Results
Elucidation of the N-domain Mg
2+-ATP coordination site
Before interpreting the structure/function relationships of
Wilson disease mutations and studying Mg
2+-ATP binding, the
first step has been the generation and experimental validation of
the 3D models for ATP7B. The NMR structure of the N-domain
has been solved without ATP coordinates, the precise binding site
of ATP being still under debate. Experimental NMR data is
available that could help to locate the binding site. Signals have
been identified between ATP and G1099, G1101, G1149 and
N1150 residues, suggesting a close proximity with ATP [11].
Compared to other P-ATPases, structural information is lacking
for the PIb-ATPase subtype concerning the direct interaction
between the N-domain and ATP molecule [20]. This emphasizes
the question about the definition of the ATP coordination site of
ATP7B N-domain as well as the role of magnesium and the two
glycine amino acids (G1099, G1101) previously mentioned. These
two glycines, which are conserved in the PIb subtypes, belong to a
region mentioned as a poly-glycine loop (
1099GXGXG
1103). This
region has already been considered to be important in nucleotide
binding to the Zn
2+ transporting ATPase (ZntA) [21].
We first identified the N-domain residues capable of interacting
with Mg
2+. According to the statistical analysis performed with a
bioinformatics database, the most probable residues able to
coordinate Mg
2+ are aspartic (33%) and glutamic (18%) acids
(Figure S1). Then, we refined this analysis by mapping the N-
domain protein surface with a spherical pharmacophore especially
designed for respecting the specific geometrical and chemical
constraints for an ideal Mg
2+-ATP binding site (see Methods
section). The Figure S2 shows the result of the pharmacophoric
search that reveals a unique possible Mg
2+ coordination site. This
site is located in a region of the protein carrying a ‘‘DDE’’
structural signature between a3 and a4 helices involving side-chain
oxygen atoms of residues E1152, D1167 and D1171 (Figure 2A).
In addition, the Mg
2+ binding site proposed is located nearby the
region known for participating to ATP binding (G1099, G1101,
G1149 and N1150).
To validate first the magnesium coordination proposed here
and prior to the interpretation of the nucleotide binding effect
studied by MD simulations, structural analysis of binding
structural analysis of binding sites has been performed. More
than 300 nucleotides binding sites using Mg
2+ ion and ATP have
been analyzed (see Methods section). The presence of aspartic and
glutamic residues in these Mg
2+-ATP binding sites reinforces the
Figure 1. General organization of the ATP7B protein. (A) The different domains of the protein are presented: the six Copper Binding Domains
(CBD), the transmembrane domain (domain M), the Actuator domain (A), the Phosphorylation domain (P) and the Nucleotide-binding domain (N).
The different domains, which have been structurally characterized, are framed in black. (B) Sequence and structure available for the N-domain.
Secondary structures and the dynamic loop are shown along with the position of the poly-glycine loop (GXGXG).
doi:10.1371/journal.pone.0026245.g001
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ion (Figure S3).
Experimental validation of the Mg
2+-ATP coordination
site
The contribution of the different regions of the protein taking
part in the interactions with the nucleotide (phosphate tail, ribose
and adenine moieties) was ‘‘tested’’ experimentally. The aim was
to validate the binding site proposed through binding measure-
ments of the nucleotide with Wild Type (WT) and mutated forms
of the N-domain (Table 1). It shows first that the presence of the
magnesium ion increases the nucleotide affinity of more than 30%
for the N-domain. The dissociation constant (Kd) for the WT
decreases from 74.2562.52 mM (ATP alone) to 51.9462.79 mM
(ATP, Mg
2+). The substitution of any of the three residues of the
‘‘DDE’’ motif coordinating the Mg
2+-ATP complex with an
alanine (E1152A, D1167A or D1171A) significantly decreases the
affinity for the nucleotide. The increase of the Kd ranges from
33% (D1171A) to more than 146% (E1152A) for Mg
2+-ATP.
Mutation of E1152A has the most marked impact on the ATP and
Mg
2+-ATP bindings. This may suggest a major role for the E1152
residue in the stabilization of the nucleotide. However, single point
mutations do not prevent, if they markedly reduce, neither ATP
nor Mg
2+-ATP binding. The role of these ‘‘DDE’’ residues is
evidenced by the absence of specific Mg
2+-ATP binding to the N-
domain (Kd.1 mM) for the triple mutant (E1152A+D1167A+
D1171A). It is interesting to note that this triple mutation also
prevents ATP binding. To prepare the positioning of the
nucleotide in the molecular modeling study, the N1150 was
mutated to alanine (N1150A). This residue has been described
previously as ‘‘close contact’’ with ATP. As for the others mutants,
N1150A shows an increase in ATP binding affinity in presence of
Mg
2+ (17%). Compared to the WT, there is a slight perturbation
of the ATP binding evidenced by the 11–33% drop of the Kd (+/
2 Mg
2+).
MD simulation study of the WT-Mg-ATP complex
Once the Mg
2+ coordination site has been ‘‘validated’’, a new
ATP binding site could be proposed, taking into account all
experimental and structural information already gathered (Table
S1). The nucleotide was first positioned by molecular docking and
was allowed to evolve along the MD simulation process to ensure
proper Mg
2+-ATP positioning through coordination of the
phosphate tail. First, the N-domain was simulated through two
different systems for 50 ns: WT and WT-Mg-ATP. Then, the
structural validation of these two models was performed. The
validation of the in silico models was done by comparing theoretical
NMR chemical shifts to experimental data [22]. The Figure S4
shows an excellent agreement between calculated and experimen-
tal chemical shifts for Ca carbon atoms of the N-domains. A high
correlation coefficient (R$0.95) and a small dispersion of the
scatter plot indicate that our 3D models are accurate. For the MD
simulation, the stabilization of the Root Mean Square Deviation
(RMSD) is achieved after 30 ns for the WT-Mg-ATP and WT
Figure 2. Mg
2+-ATP coordination site within the N-domain (WT-Mg-ATP complex). (A) The surface of the protein is displayed with the main
regions implied in interactions with ATP that are colored following the internal text label. A close view of the binding pocket is presented with a3/a4
helices (light blue) in ribbon representation with amino acid side-chains and ATP, with Mg
2+ ion (purple sphere), in ball and stick representation.
Carbon, oxygen, nitrogen, and phosphorous atoms are colored in gray, red, nitrogen, and orange, respectively. (B) Topological diagram of the
secondary structures of the N-domain. Cylinders and arrows represent a-helices and b-strands, respectively. The nucleotide is shown with three
different parts: Adenine (blue), Ribose (magenta) and Phosphate tail groups (orange). For illustration, glycine and dynamic loops are colored in green
and purple, respectively. (C) 2D representation of the singular amino acids involved in direct interaction with magnesium ion or ATP atoms. Amino
acids framed in red have been mutated (see Experimental section).
doi:10.1371/journal.pone.0026245.g002
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domain interacting with Mg
2+-ATP shows a similar behavior to
the nucleotide free N-domain. This is evidenced by the
calculations of the RMSD: 9.9 A ˚ and 8.6 A ˚ for the RMSD of
the N-domain alone (WT) and interacting with Mg
2+-ATP (WT-
Mg-ATP), respectively. The same result is obtained when the
evolution of the RMSD is measured by excluding the ‘‘dynamic’’
loop (A1114-T1143). A similar trend is observed for the radius of
gyration evolutions (Figure 3B). The Rg fluctuates around an
average value of 16.5 A ˚ for WT and 15.6 A ˚ for the WT-Mg-ATP
systems. Ramachandran plots show an increase in geometrical
relaxation parameters for the structures of the N-domain between
the initial and the representative structure of the last 20 ns of MD
simulations (Figure S5). The initial WT N-domain structure has
73% of amino acids residues in the most favourable regions, whilst
the representative structure of the last 20 ns of MD simulations
reaches 84% for the WT and the WT-Mg-ATP systems.
Based on these MD preliminary results, we further investigated
the Mg
2+-ATP coordination site on the WT-Mg-ATP model. The
position of the nucleotide for the representative structure of the last
20 ns of MD simulation is shown in Figure 2A. The magnesium
ion is located near a3 and a4 helices (coordination helices). They
bear the ‘‘DDE’’ motif and are located close to the glycine loop
(
1099GXGXG
1103). The Figure 2B shows an overall ‘‘picture’’ of
the new binding site where the adenine part of the nucleotide is
located near the glycine loop and the b-sheets ‘‘core’’ of the N-
domain. A close view in the nucleotide-binding environment is
shown (Figure 2C). The magnesium ion is hexacoordinated via an
octahedral geometry by the amino acids of the ‘‘DDE’’ motif
(E1152, D1167, D1171) and oxygen atoms of the b-/c-phosphate
group of ATP. For the ribose part, N1150, W1153 and C1100 are
the main protein residues in close interaction. The hydrogen bond
between the backbone of C1100 (C=O) and one of the hydroxyl
groups of the ATP ribose moiety has a 22% lifetime. The adenine
moiety interacts essentially with P1098, G1099 of the glycine loop.
The N1150 side-chain also interacts with one nitrogen atom of the
adenine moiety. The E1152 residue interacts with the ion through
bidentate coordination (Figure S6). In the WT-Mg-ATP MD
simulation, the Mg
2+ coordination is stable as shown by the
average Mg
2+-O distance (Figure S6). For the oxygen atoms of the
side-chains of the ‘‘DDE’’ motif (E1152, D1167, D1171) and for
the part of ATP interacting with the ion, the Mg
2+-O distance is
close to 2 A ˚ ([1.84 A ˚– 1.96 A ˚]). This is compatible with previous
structural data available on magnesium binding in proteins [23].
Neither the residues surrounding the coordinating sphere nor
water molecules of the bulk solvent were able to induce any
perturbation of the Mg
2+-ATP coordination throughout the
duration of MD simulation. The stabilization of the RMSD
obtained after 30 ns for both simulations and the structural
validation allow a further analysis of the nucleotide binding impact
on each region of the N-domain. The general trend is a decrease
in the atomic fluctuations for several regions of the protein when
Mg
2+-ATP is bound to the N-domain (Figure 3C). It appears that,
at least, the movements of three regions are influenced by the
presence of the nucleotide: the poly-glycine loop, the ‘‘dynamic’’
loop and the ‘‘coordination helices’’. The glycine loop that is
located between the two b-strands (b2, b3) and the dynamic loop,
shows a noteworthy stabilization in the presence of the nucleotide.
For example, the presence of ATP decreases the fluctuation of
residues 1091–1099 with P1098 being the most important affected
residue (2.3 A ˚ versus 0.6 A ˚ without ATP). The ATP presence
under the loop enforces the two b-strands to accommodate their
relative position. A hydrogen bond network rearrangement is
occurring between the two b-strands with an increase in plasticity
of the b2, which demonstrates a high potential of structural
accommodation. The most marked effect of the Mg
2+-ATP
binding on the motions of the protein is observed for the long
dynamic loop (A1114-T1143). Mg
2+-ATP interactions reduce
substantially the motion of several residues i.e. E1117 (21.8 A ˚),
R1118 (22.6 A ˚), P1119 (23.2 A ˚), L1120 (23.4 A ˚), S1122
(22.5 A ˚). The fluctuation of the ‘‘coordination helices’’ is also
decreased. Indeed, the most significant difference between the MD
simulations with or without Mg
2+-ATP is seen for T1170 (21.8 A ˚)
and E1171 (21.4 A ˚).
ATP binding site without Mg
2+
To assess the effect of Mg
2+ on ATP binding to the N-domain,
MD simulation was performed without the ion (WT-ATP system).
The absence of the ion induces conformational changes in the N-
domain with a major rearrangement concerning the a3 and a4
helices that can be explained by a decreasing structural order
through MD simulation results of WT-ATP system. For the WT-
ATP system, the stabilization of RMSD occurs after 20 ns (Figure
S7A).
Computational results show that in absence of Mg
2+, the N1150
is still in the vicinity of ATP molecule and interacts in this case
(WT-ATP) with the phosphate moiety (O-Pc) through hydrogen
bond interaction (2.11 A ˚). Instead of interacting with Mg
2+ ion
(WT-ATP-Mg system), the D1171 amino acid forms a strong
hydrogen bond with the hydroxyl group of the ribose moiety in
absence of Mg
2+ (WT-ATP system) (Figure S7B). In addition, the
adenine moiety is encapsulated by M1035, P1098, I1102, I1138,
G1149, M1174, I1180, and I1194 residues defining a hydrophobic
pocket. Moreover, the amine group of adenine moiety forms
hydrogen bond with carbonyl backbone of C1100 amino acid
(2.87 A ˚). Molecular modeling results are confirmed by experi-
mental data showing that ATP is able to bind the N-domain
without the magnesium ion (Table 1). However, the affinity of the
N-domain for ATP is 45% lower when Mg
2+ is absent. All the
above results suggest a more complex interaction between the N-
domain and ATP than it has been previously suggested and
reinforces the validity of a new ATP binding mode in absence of
Mg
2+ ion.
Table 1. Nucleotide binding affinity for the N-domain of Wild
Type and mutant proteins.
N-domain Kd (mM)
ATP ATP, Mg
2+
Wild-type (WT) 74.2562.52 51.9462.79
E1152A 174.3163.82** 128.8462.74**
D1167A 96.9263.91** 80.9662.52**
D1171A 81.1263.16* 68.0462.71*
E1152A+D1167A+D1171A no binding** no binding**
N1150A 82.7464.16* 68.3362.82*
D1121–1137 no binding** no binding**
H1069Q 76.5261.72 54.3761.66
The affinity is presented here via the dissociation constant Kd for the complex:
N-domain- Mg
2+-ATP (left column) and N-domain/ATP (right column). The
amino acids belonging to the coordination helices are highlighted in light blue,
the deletion of the dynamic loop is shown in purple.
No binding (Kd.1 mM),
*P,0.05,
**P,0.01.
doi:10.1371/journal.pone.0026245.t001
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2+-ATP
binding
As evidenced in the dynamic study of the Wild Type N-domain
(WT), the motion of the long loop located between A1114 and
T1143 is influenced by the presence of Mg
2+-ATP. This striking
change of motion suggests a possible contribution of this loop in
ATP binding. Located between b3 and b4 (Figure 3B), this loop is
only present in human P-ATPases such as ATP7B and ATP7A.
The latter is a copper transporter highly homologous to the
ATP7B protein, implicated in Menkes disease [24]. This explains
why the role of this loop remains unknown besides an increasing
numbers of structural studies actually available for these enzymes.
According to the results obtained for the atomic fluctuations of the
long loop, further investigations have been made to understand the
role of this peculiar loop in the ATP7B function. First, the effect of
the loop on the nucleotide binding was evaluated experimentally
by the measurement of the Kd for a mutant protein with a
shortened loop (deletion of residues 1121–1137). Unexpectedly,
the absence of this loop suppresses the binding for both ATP and
Mg
2+-ATP (see Table 1). In order to understand these results and
to elucidate furthermore the role of this loop in the N-domain
dynamic response and its influence on the nucleotide binding
process, one additional MD simulation has been performed. For
this purpose, a new 3D model was built with the long ‘‘dynamic’’
loop substantially shortened (Shortened Loop SL, cf. Methods). No
alteration of overall protein folding has been noticed, compared to
WT-ATP-Mg model. The RMSD obtained for the SL-Mg-ATP
system shows stabilization after 20 ns of MD simulations (Figure
S8A). The Mg
2+-ATP binding site is altered in absence of the
whole loop with a re-organization of the magnesium coordination
Figure 3. Analysis of the N-domain plasticity along MD simulations for WT and WT-Mg-ATP systems. (A) Root Mean Square Deviation
(RMSD) of the Caatoms with the initial minimized structure used as reference for the 50 ns of MD simulations: whole Wild-Type protein of the N-
domain (WT, green) and Mg
2+-ATP complexed to the N-domain (WT-Mg-ATP, red). Purple and blue colors represent the RMSD of the Ca atoms
calculated without taking into account the dynamic loop (A1114-T1143) for WT and WT-Mg-ATP system, respectively. All structures were previously
fitted to the initial structure of the MD simulation considering the WT for all trajectories. (B) Radius of gyration of Ca atoms for WT and WT-Mg-ATP
systems. Color scheme is the same as previously defined. (C) Atomic fluctuations of Ca atoms for WT (green) and WT-Mg-ATP systems (red).
doi:10.1371/journal.pone.0026245.g003
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evicted and replaced by a water molecule (Figure S8B). The
coordination helices loose their structural integrity. This allows the
nucleotide to change its relative position concerning the
coordination helices and the poly-glycine loop. It goes further
‘‘inside’’ the b-sheet core of the protein composed of a
hydrophobic groove (I1119, I1180, I1194). The phosphate part
of ATP is stabilized via an interaction with R1156. The adenine
moiety looses its main interactions. These preliminary data on the
loop role suggest interdependence between the motions of the
dynamic loop and the Mg
2+-ATP binding site via a possible
affinity modulation of the Mg
2+-ATP/N-domain complex.
Discussion
Like in the case of WD, access to in silico technologies for
studying the pathophysiology of rare genetic disorders, bring
additional arguments for facilitating the diagnostic and the
prognostic of diseases that are sometimes difficult to establish. A
prerequisite for the study of the impact of point mutations on a
protein structure is to understand its natural structural properties
like folding, atomic motions, conformational changes, interaction
with cofactors, etc. In the present work, the focus was the
identification of the Mg
2+-ATP complex binding site of the N-
domain (WT). The scientific literature is abundant on P-ATPases.
Many studies are focused on their catalytic cycle with an emphasis
on the phosphorylation step [25] and the general role of ATP [20].
Less attention has been paid to the nucleotide-binding step.
Structural studies have been published using molecular modeling
tools to decipher at the molecular level the interactions between
the protein and the nucleotide. For ATP7B, the first molecular
modeling study was anterior to the publication of the NMR
structure of the N-domain [15]. The putative three-dimensional
(3D) model of the N-domain was obtained by homology modeling
using the Sarcoplasmic Reticulum Ca
2+-ATPase (SERCA) as a
structural template. The study did not lead to significant results
concerning the ATP binding process. The low primary sequence
homology between the N-domain of ATP7B and SERCA (20%)
led to a poorly accurate 3D model with two putative ATP binding
configurations proposed in the same protein without any presence
of Mg
2+. Most of all, no experimental validation of the molecular
interactions has been performed.
For the other members of the closely related P-ATPases, no
molecular dynamics study of the nucleotide coordination is yet
available. An NMR structure has been recently solved for the N-
domain of ATP7A in the nucleotide bound (without Mg
2+) and
nucleotide free forms [26]. An observation of the ATP-bound
structure (PDB Id. 2KMX) shows an overall domain organization
similar to the ATP7B N-domain. However, the topology of the
ATP7B nucleotide-binding site is rather different especially for the
phosphate groups. Both proteins share key residues: P1098 (P1087
for ATP7A), G1099 (G1116), G1101 (G1118), N1150 (N1184).
Another key element is the sequence conservation in both N-
domains of the residues belonging to the ‘‘DDE’’ motif responsible
of the Mg
2+-ATP coordination in the WT-Mg-ATP model: E1157
(E1186), D1167 (D1201), and D1171 (D1205). The absence of
Mg
2+ in the ATP7A NMR structure could explain the differences
observed in the nucleotide environment of two proteins. The
possible modification of ATP conformation in presence of Mg
2+
has been briefly evoked in the NMR study of the ATP7B N-
domain [11] suggesting the existence of two different binding
‘‘sites’’ with different affinities for ATP. This hypothesis could
explain the difference of the experimental Kd obtained for the WT
in magnesium free or bound form (Table 1).
In order to challenge this assumption, MD simulations have
been performed for the wild type ATP7B N-domain in interaction
with either ATP or Mg
2+-ATP (WT-ATP and WT-Mg-ATP
systems). Indeed, ATP alone could accommodate its position by
migrating towards a hydrophobic groove after the removal of the
magnesium ion. The charge repulsion between phosphate tail of
ATP and acidic side-chains of the residues belonging to the
‘‘DDE’’ motif of the Mg
2+ coordination sphere could help ATP to
shift. Two binding modes could exist in the N-domain whether the
ion is present or not. The first binding mode needs Mg
2+ for ATP
binding to be tightly stuck to the N-domain, the second being a
transitory binding mode before the migration of the nucleotide
towards the P-domain. Indeed, the c-phosphate hydrolysis is thus
not possible for phosphorylation of the P-domain since it is
engaged in the ion coordination through its oxygen atoms. For
proper P-domain phosphorylation, ATP has to be separate from
Mg
2+. This transition might be possible through a conformational
change of the N-domain (see below for Discussion about the
dynamic loop) since the N-domain and Mg
2+-ATP complex are
stuck together through very strong electrostatic interactions. It
would be interesting to test this hypothesis with a 3D model of N-/
P-domains together to study the whole process from the
nucleotide-binding step to the phosphyralation. This hypothesis
is in agreement with the fact that Mg
2+-ATP complex has to
change its coordination when approaching the P-domain in order
to allow its phosphorylation at D1027, as evidenced in a previous
study concerning the SERCA structure solved in presence of ATP
and Mg
2+ [27]. A recent study of the CopA protein, a bacterial
homolog of ATP7B, clearly brings a bundle of arguments in the
favor of our hypothesis. In the crystal structure of the protein
solved with an ATP analogue in presence of the magnesium ion
[28], the nucleotide is bound in ‘‘sandwich’’ between the N- and P-
domains nearby H1069 but not directly interacting with, and
associated on the P-domain side with a hexacoordinated Mg
2+ ion.
It is interesting to note that there is no equivalent ‘‘DDE’’ triad in
the N-domain of the CopA. More recently, a nearly complete X-
ray structure has been published for this protein [29]. The
presence of a magnesium ion near the DKTG motif at the
interface of the P- and the A-domain support our hypothesis and
could help to elucidate the full transfer of Mg-ATP from N- to P-
domain during the acyl-phosphorylation process.
The previously published structural studies on the N-domain
have neglected the role of the Mg
2+ ion, although experimental
evidences have pointed out the major role it plays in the
nucleotide-binding mode of different P-ATPases. An original
experimental protocol was used to study the ATP binding site of
the Na
+/K
+ ATPase with Fe
2+ ions capable of replacing Mg
2+
[30]. A direct interaction was proposed between an ATP-Fe
2+
complex and the aspartic acid side-chains of the ‘‘VADGA’’ motif
(N-domain). Similar results for the SERCA have been confirmed
by the interactions of residues of the N-domain and Mg
2+-ATP
[31]. The results obtained in the present study prove the essential
role of the ion in the nucleotide binding to the N-domain as it
accounts for a substantial part of the binding affinity. Theses
results are in agreement with the previous experimental study
published by Morgan et al. [17]. Indeed, a significant increase in
affinity was measured with similar results for the Kd: 75.30 mM
(63.62) for ATP alone to 57.00 mM( 63.00) for the Mg
2+-ATP
complex (Table 1). It was concluded surprisingly that the
nucleotide binding to the N-domain is a magnesium-independent
event despite contradictory experimental results. The reason was
that no high-affinity binding has been observed in presence of N-
domain and magnesium alone. Unfortunately, this publication has
been often referred for justifying the lack of Mg
2+ participation in
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2+ always
helps nucleotide to bind optimally to the protein target. It is well
known that Mg
2+ is essential for the catalytic activity of a wide
range of enzymes using a nucleotide as cofactor (kinases, G-
proteins, polymerases, etc, for review see reference [32]). In
addition, the very low intracellular proportion of ATP in the free
form, the cytosolic abundance of Mg
2+ (,10
23 M) and the
important stability of the Mg
2+-ATP complex (Ka<10
4 M) explain
why this complex is the major active form of the nucleotide [33].
This has been confirmed in muscle tissues where Mg
2+-ATP
accounts for 90% of total ATP [34]. The position of the ion in
coordination with b- and c-phosphate oxygen atoms protects the
nucleotide from hydrolysis. This fundamental role of the
magnesium in binding sites is achieved through a hexacoordina-
tion under an octahedral geometry.
Our results show noticeable disparities with previously pub-
lished work concerning the ATP binding site. A major difference
concerns H1069 residue that has been shown to bind directly ATP
without considering the role of the magnesium ion [11,16]. H1069
residue has been proposed to participate directly in ATP binding
since the H1069Q mutation occurs frequently in WD. Its
participation in ATP binding is not obvious and has to be
reconsidered for both modeling and binding experiments. Indeed,
the distance between ATP and H1069 is about 9–10 A ˚ for the
WT-Mg-ATP system that is not compatible with a direct
participation of the histidine in the binding site. Similarly, the
simulation of WT-ATP model reveals a distance between ATP
molecule and H1069 about 17 A ˚ (distance in the representative
structure) that indicates no direct participation in the ATP vicinity.
Experiments confirmed this conclusion. The binding measurement
repeated eight times for the H1069Q mutant is not different from
the WT protein in both magnesium free and bound conditions
(Table 1). Previous experimental results suggest a perturbation of
ATP binding with a decrease in ATP affinity even though results
are not reproducible. The first experimental measurement for the
H1069Q mutant performed by isothermal titration calorimetry
reported a substantial decrease in ATP binding affinity (Kd was
estimated around 1200 mM) [17]. No alteration of the protein
folding was reported. Then, Rodriguez-Granillo et al. obtained
with the same method different results for the H1069Q mutation
with only a two-fold decrease in affinity (Kd increase) as compared
to the WT-ATP (344 mM for H1069Q and 166 mM for the WT)
[16]. Moreover, the role of the magnesium ion was not considered
in the binding experiments for the mutant. Such contradictory
results leave the question amid controversy concerning the direct
participation of the H1069 residue to the nucleotide binding.
Another hypothesis has been proposed to explain the impact of the
H1069Q mutation on the protein function. It was reported a total
loss of phosphorylation of the conserved catalytic aspartic acid
residue located in the P-domain [35]. This was observed without
any alterations of the folding. This result is in agreement with the
present work where the H1069 is far from the nucleotide-binding
site and located close to the N-/P-domains interface. Similarly,
Kenney and Cox reported that H1069Q mutation impacts on
membrane expression due to the accumulation of the protein in
the Golgi apparatus or in the endoplasmic reticulum [4]. All the
above observations reinforce our findings.
Based on these fundamental data combined with in silico and
structural biology techniques, we succeeded to clearly define the
Mg
2+-ATP N-domain binding site. Mg
2+-ATP binding stabilizes
the N-domain and reduces its internal atomic motions, particularly
for the poly-glycine loop, the dynamic loop region and the N-
terminal extremity of the protein. This latter observation remains
to be clarified. This terminal part in our models evolves freely,
whilst in the structural context of the whole ATP7B protein, it is
buried and connects the N- and P-domains. The N-terminal
extremity moves towards the nucleotide and close to the glycine-
rich loop. That is not the case in the nucleotide free simulation of
the WT system. The flexibility of this region had already been
incriminated in different structural studies as responsible for the
rotation of the N-domain towards the P-domain, a necessary
conformational change in the phosphorylation step of the catalytic
cycle of these enzymes [36,37]. In addition, in the full protein, this
N-terminal extremity bears the ‘‘DKTG’’ consensus motif of the
P-ATPases suggesting that a possible local conformational change
could regulate the catalytic activity of the enzyme. Let us bear in
mind that all above conclusions are made on 3D models using the
N-domain as a template. It would be interesting to study the
impact of the nucleotide effect and the role of the long ‘‘dynamic
loop’’ on the protein motions on the whole N-/P-domains.
We have also shown that shortening the dynamic loop results in
a perturbation of ATP binding such as an alteration of the
interactions in the Mg
2+ environment. Indeed, the octahedral
Mg
2+ coordination is modified with the removal of D1167 residue,
which is replaced by a water molecule (Figure 4A). This
modification could be due to the perturbation of the a3/a4
helices. The presence of the loop only in ATP7B among all the
ATPase protein family suggests an original participation of this
loop to the allosteric regulation of ATP binding. Indeed, it could
be argued that the reduction of this loop motions could facilitate
phosphorylation of the ATP7B P-domain by inducing a decrease
in the Mg
2+-ATP binding force to the N-domain. Moreover, a
possible unknown protein partner could interact with the loop
protruding in the cytosol, out of the Golgi membrane (Figure 4B).
All the above data open up a new way for additional experimental
investigations for characterizing this putative dynamic loop
partner. It could be an unknown protein or another domain of
the ATP7B protein. Indeed, a direct interaction between the
complex formed by association of the N- and the P-domains and
the N-terminal Copper-Binding Domain has been demonstrated
[38].
In summary, we provided a clear definition of the topology and
localization of the Mg
2+-ATP binding site by using a careful in
silico protocol. Through the N-domain protein, the ‘‘DDE’’ motif
(E1152, D1167, D1171) is able to coordinate the ion via an
octahedral geometry (Figure 2). The absence of the Mg
2+ ion led
to a topology description of a transitory binding mode that could
play an important role before the phosphorylation of the P-
domain. Computational results such as the intervention of the ion
or the role of the dynamic loop have been confirmed
experimentally. The binding measurements have shown that the
nucleotide is able to bind the N-domain with a submicromolar
affinity in presence of Mg
2+ ion. Most of all, the possible allosteric
role by the long dynamic loop in the N-domain Mg
2+-ATP
binding/release was put forward. All above results pave the road
for additional investigations of the impact of mutations on the
folding and function of the N-domain.
Methods
Structural analysis of Mg
2+-nucleotide binding site
In order to find the ATP7B N-domain Mg
2+-ATP binding site,
a database search was done on the MSD motif database of the
European Bioinformatics Institute [39]. It contains 19 042
different bonds interacting between amino acids and Mg
2+ ion.
The results are ranked for every amino acid participating to Mg
2+
coordination in a decreasing order of occurrence probability
(Figure S1). Then, based on this classification, a pharmacophore-
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site in the N-domain of ATP7B. The 3D structure of the N-
domain is inserted on 3D grid of points with 1 A ˚ between each
point. Its surface is then mapped using a pharmacophore of an
ideal Mg
2+ coordination geometry (Figure S2). Each pharmaco-
phoric point was designed according to functional chemical groups
of the amino acid side-chains involved in the Mg
2+ ion
coordination. As an example of the most represented coordinating
residues, it contains different pharmacophoric points (Asp, Glu,
etc.). The definition of pharmacophoric points includes a sphere
centered on Mg
2+ with Ca atoms bearing active points. The sphere
radius is adjusted depending on the volume of every atom of the
side-chains (Asp, Glu, etc.), the number of residues to be included
and their relative orientation. The 6 A ˚ diameter of the sphere
takes into account the volume of the spheres for the oxygen atoms
and Mg
2+ based on their respective Van der Waals radii (1.52 A ˚
and 1.71 A ˚). This is compatible with the fact that experimental
Mg
2+-O distance is rarely superior to 3 A ˚. The mapping
procedure was repeated several times by varying systematically
the nature of each pharmacophoric point and by respecting the
occurrence probability of each amino acid obtained by the
previous ranking procedure with an emphasis on acidic residues.
The validation of the Mg
2+ nucleotide coordination site was
achieved by performing a careful 3D visual analysis of 3D
structures containing magnesium, ATP or analogues available in
the Protein Data Bank (PDB). First, 72 proteins containing a
nucleoside triphosphate hydrolase P-loop structural motif were
studied (SCOP classification [40]). Next, the analysis was extended
to 97 proteins bearing a Rossman fold (CATH classification [41]).
Finally, we expanded our PDB ‘‘scan’’ to 314 matching structures
sharing the same nucleotide binding function as the N-domain
(Gene Ontology term 166). Every nucleotide-binding pattern was
carefully analyzed with the help of PyMOL visualization program
[42].
Molecular dynamics simulations
The NMR ‘‘model 1’’ structure of the N-domain of the ATP7B
protein (PDB code 2ARF) was used as a starting structure for
molecular dynamics (MD) simulations with the help of the
GROMACS molecular dynamics package [43]. The WT and
shortened N-domain (Shortened Loop: SL) isolated species as well
as complexed with either ATP (WT-ATP) or Mg
2+-ATP (WT-Mg-
ATP) were simulated. The initial position of the nucleotide was
obtained from molecular docking using the WT model obtained
from MD with the magnesium ion positioned near the ‘‘DDE’’
motif. Conformational space for ATP positioning was performed
taking into account the residues highlighted from experimental
and structural informations (Table S1). Then, calculations were
done using AUTODOCK 4.2 [44]. 200 docking runs with
Lamarckian Genetic Algorithm as a conformational search engine
were done and results were clustered with a RMSD tolerance of
2A ˚. The lowest energy conformation of the most populated
cluster was then considered for following MD simulations.
All studied systems were prepared using Ambertools package
[45]. The protein and the magnesium ion (Mg
2+) were described
with the FF03 force field for proteins [46,47]. ATP parameters
were obtained from GAFF force field [48] and additional revised
parameters [49,50]. Topology and coordinates files obtained from
tLEaP were then converted to GROMACS file format using
Acpype [51] python tool based. Each model was solvated in a
rectangular water box with a 12 A ˚ layer of TIP3P water
molecules. The protein residues were considered at neutral pH.
Thus, HIS residues were kept in the default neutral protonation
state (HID, with hydrogen on the delta nitrogen) in Amber FF03.
Figure 4. Implication of the flexible loop in ATP binding. (A) Closest trajectory snapshot of the representative structure for the whole and
shortened N-domain (cartoon representation) for the WT-Mg-ATP (left) and SL-Mg-ATP (right) systems. The amino acid D1167 is circled in red and
side-chains of the ‘‘DDE’’ motif are presented in sticks. ATP and water molecules are shown in ball and stick and VdW, respectively. (B) Schematic
proposition of allosteric mechanism promoted by the dynamic loop for the nucleotide release process. The first step of the dynamic response of the
loop implies a constraint applied by an unknown partner. The second step is the perturbation of the binding of ATP with the N-domain.
doi:10.1371/journal.pone.0026245.g004
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appropriate number of Na
+ counter ions. Energy minimization
protocol included 5000 cycles of Steepest Descent algorithm with
convergence criteria of 500 kJ.mol
21.nm
21. The electrostatic non-
bonded interactions were computed with a 12 A ˚ cut-off and
particle-mesh Ewald method [52] to treat long range interactions.
Lennard-Jones potential was described with a continuously
smoothing cut-off from 10 to 12 A ˚. A constant temperature/
pressure simulation with a 1 fs time step under leap-frog algorithm
for integrating Newton’s equations of motion was performed. A
total of 50 ns simulations were done for each system at 310 K in
the NPT ensemble (constant number of particles, pressure, and
temperature) with temperature velocity rescaling coupling [53]
and at 1 atm pressure with Berendsen isotropic coupling [54]. The
study of the impact of the large dynamic loop (residues A1114 to
T1143) on the N-domain/Mg
2+-ATP complex was investigated by
shortening the loop (lacking residues 1121–1137) and by linking
residues 1120 and 1138 to give SL-Mg-ATP system. The
geometrical quality of the different representative 3D structures
throughout the simulations was assessed by Ramachandran plots
generated by the PROCHECK program [55] (Figure S5). For
protein-ligand interactions studies and other analyses, representa-
tive structures were extracted using the closest frame from the
representative structure over the last 20 ns of each trajectory.
Hydrogen bonds have been considered with precise geometrical
parameters: 3.2 A ˚ donor-acceptor distance cutoff and a 30u angle
cutoff.
Protein expression and purification
To analyze the pertinence of the Mg
2+-ATP binding site,
functional profiles of engineered N-domains of ATP7B (amino
acid residues V1036-D1196 of the full-length protein) were
determined. The corresponding cDNA region was PCR-ampli-
fied and subcloned as previously described [17]. Mutations were
introduced using the QuickChange site-directed mutagenesis kit
(StratageneH) and verified by DNA sequencing (3130 Genetic
Analyzer, Applied Biosystems). Wild type or mutated cDNAs
were then expressed and the corresponding proteins were
purified. To avoid transcriptional bias, cell lines expressing
comparable amounts of RNA from cDNA were selected by
Taqman analysis.
Nucleotide binding experiments
Surface Plasmonic Resonance was used to determine the
binding properties of WT and several mutants of N-domain with
ATP and Mg
2+-ATP. The ATP7B/ATP and ATP7B/ATP, Mg
2+
interactions were determined by surface plasmon resonance (SPR,
BIAcore AB, Uppsala, Sweden) at 25uC using 10 mM sodium
phosphate (pH 7.40) containing 150 mM NaCl as running buffer
(phosphate-buffered saline, PBS). The flow rate was 5 mL/min
during immobilization. Purified Wild Type and mutated ATP7B
were covalently immobilized onto the hydrophilic carboxymethy-
lated dextran matrix of the sensor chip CM4 previously activated
with 35 mL activation solution, as described by the manufacturer.
We used 10 mL (1 mM) of ATP or ATP +12 mM MgCl2 (Sigma)
dissolved in 10 mM sodium acetate (pH 5.00). A reference surface
was subjected to the same procedure, but with no protein. The
chip was blocked using 35 mL of blocking solution (1 M
ethanolamine hydrochloride, pH 8.50). We then injected the
ATP or ATP+Mg
2+ solution and collected data at a flow rate of
30 mL/min. Data were analyzed by nonlinear curve fitting using
the manufacturer’s software. Each binding experiment was
repeated several times (n=6–8) under both conditions.
Spectral characterization of theoretical models
The experimental validation of the generated 3D models was
performed by comparison between the available NMR chemical
shifts of the N-domain and ‘‘theoretical’’ chemical shifts calculated
from MD trajectories. The various assigned experimental
chemical shifts were extracted from the BioMagResBanK (entry
number 6914). Apart from general NMR parameters such as
relaxation times (T1,T 2), the chemical shifts are not available
directly from simulation data. The SPARTA program [22]
predicts protein backbone chemical shifts (
15N,
1H
N,
1Ha,
13Ca,
13Cb,
13C9) from a PDB file. According to the elevated Pearson’s
correlation coefficient (R=0.91) between experimental and
SPARTA predicted chemicals shifts calculated for
13Ca atoms,
we decided to use these atoms to evaluate the correlation between
experimental and calculated NMR shifts from our 3D models.
Supporting Information
Figure S1 Bar chart showing the proportion of the different
amino acids involved in Mg
2+ coordination (source EBI). The
percentage of magnesium ion interacting with either an aspartic or
a glutamic acid is shown.
(DOC)
Figure S2 N-domain screening procedure used for identification
of the Mg
2+ binding coordination site. The N-domain is
represented in cartoon, aspartic and glutamic acids side-chains
in sticks. The pharmacophore presented here is an example of a fit
obtained with Mg
2+ and three amino acids (Asp, Asp, Glu). The
result of the protein surface mapping is green circled and two
important regions of the protein known to play a role in ATP
binding are shown with black arrows (G1149-N1150, GxG motif).
(DOC)
Figure S3 Examples of the Mg
2+ coordination environment in
different ATP-binding proteins: (A) Human nicotinamide riboside
kinase, (B) yeast mitochondrial F1-ATPase, (C) GlcV, bacterial
ABC-ATPase of the glucose ABC transporter, (D) ATPase domain
of the bovine heat-shock cognate protein. Each 3D structure is
identified with its PDB Id code. The ATP (or analogue) is colored
in gray, the magnesium sphere in purple.
(DOC)
Figure S4 Correlation plots between experimental and calcu-
lated NMR chemical shifts obtained from different structures for
the
13Ca carbon atoms of the N-domain: (A) Initial structure
available in the PDB, (B) Structure of the representative frame of
the last 20 ns of 50 ns MD trajectories of the WT-Mg-ATP system
and (C) of the WT system. Predictions of the chemical shifts were
obtained using the SPARTA software (see Methods).
(DOC)
Figure S5 Ramachandran plots of the N-domain monitoring the
structural components of the models used throughout the
molecular dynamics (MD) simulations. Initial structure after the
minimization step (upper plot), structure of the representative
frame of the last 20 ns of 50 ns MD trajectories for WT (left) and
WT-Mg-ATP systems (right). The percentage of residues found in
the most favorable regions of the diagram is indicated in a purple
rectangle for each model.
(DOC)
Figure S6 Geometrical details of the octahedral Mg
2+ coordi-
nation in the nucleotide-binding site. The trajectory snapshot of
the system WT-ATP-Mg represents atoms in close vicinity of the
ion (magenta sphere). The representative structure of the last 20 ns
of MD simulations is shown with the octahedral Mg
2+ coordina-
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PLoS ONE | www.plosone.org 9 October 2011 | Volume 6 | Issue 10 | e26245tion in the nucleotide-binding site. The distances (A ˚) related to the
octahedral coordination of the Mg
2+ are the average values over
the last 20 ns of the total dynamic simulation (50 ns).
(DOC)
Figure S7 MD analysis and alternative binding mode of the N-
domain in absence of Mg
2+ for the WT-ATP system. (A) Plot of
the Root Mean Square Deviation (RMSD, in A ˚) of the Ca,atoms
along the 50 ns of MD simulation for the WT-ATP system. (B)
Closer trajectory snapshot of the representative structure along the
last 20 ns of the 50 ns duration. Protein (WT), ATP molecule, and
side-chain residues are represented in cartoon, ball and stick, and
tube, respectively. Hydrogen bonds are shown in doted line.
(DOC)
Figure S8 MD analysis and binding mode of the N-domain
where the dynamic loop (A1114-T1143) has been shortened for
the SL-Mg-ATP system. (A) Plot of the Root Mean Square
Deviation (RMSD, in A ˚) of the Caatoms along the 50 ns of MD
simulation for the SL-Mg-ATP system (red). (B) Closer trajectory
snapshot of the representative structure along the last 20 ns of the
50 ns duration. Protein (shortened dynamic loop, SL), ATP and
water molecules, magnesium atom and side-chain residues are
represented in cartoon, ball and stick, VdW, and tube,
respectively. Hydrogen bonds are shown in doted line.
(DOC)
Table S1 Structural and experimental information used to
propose an initial binding site for ATP in the molecular dynamics
simulations. The residues highlighted in yellow green belong to the
glycine loop and light blue for the coordination helices.
(DOC)
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